@entity1211 ( @entity1211 ) is a significant cause of morbidity and mortality in @entity130 . What is known regarding @entity1211 prophylaxis has been extrapolated from nontrauma data. Optimal methods of @entity1211 prevention for @entity130 remain controversial and unknown. @entity130 @entity1 are unique and heterogeneous rendering many forms of treatment inappropriate. The most fatal complication of @entity1211 is a @entity1151 ( @entity1151 ). There is a long history of protection against @entity1151 as vena caval interruption. Inferior vena cava (IVC) filters were designed to protect against @entity1151 . Since the approval by the Food and Drug Administration for the use of retrievable filters, @entity130 care specialists are increasingly choosing this form of prophylaxis. Indications for use, efficacy, and safety of IVC filters remain debated. There is lack of rigor in studies concerning IVC filters. Filters are not without complications. Removal rates for retrievable filters are poor. Nursing is instrumental in IVC filter prophylaxis, efficacy, and safety success.

Inferior vena cava filter use as XXXX prophylaxis in @entity130 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1211 :: ('MESH:D054556', 'Disease') :: ['Venous thromboembolism', 'VTE'] @entity130 :: ('MESH:D014947', 'Disease') :: ['Trauma', 'trauma'] @entity1151 :: ('MESH:D011655', 'Disease') :: ['PE', 'pulmonary embolism']
@entity1151 :: (MESH:D011655,Disease) :: ['pulmonary embolism']
